Close Menu

Keeps on Coming

Roche is letting 6 percent of its workforce, or about 4,800 people, go, reports Ed Silverman at Pharmalot. A Roche statement on its Operational Excellence Program says that 800 cuts will be to product development staff and 600 cuts to research and early development positions, while sales and marketing will bear the largest share of the cuts, with a loss of 2,650 positions.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.